Výsledky vyhľadávania - "RNA, Viral blood"
-
1
Autori: a ďalší
Zdroj: Moseholm, E, Omland, L H, Katzenstein, T L, Pedersen, G, Johansen, I S, Storgaard, M & Weis, N 2025, 'Retention in care and viral suppression in pregnant/postpartum vs. nonpregnant/nonpostpartum women with HIV', AIDS, vol. 39, no. 13, pp. 1936-1945. https://doi.org/10.1097/QAD.0000000000004275
Predmety: Adult, retention in care, Sustained Virologic Response, sustained virologic response, Postpartum Period, Retention in Care/statistics & numerical data, HIV Infections/drug therapy, Pregnancy Complications, Infectious/drug therapy, HIV, Viral Load, Denmark/epidemiology, postpartum period, CD4 Lymphocyte Count, Cohort Studies, Young Adult, Danish HIV birth cohort, Pregnancy, Anti-HIV Agents/therapeutic use, Humans, Female, pregnancy, women, RNA, Viral/blood, Registries
-
2
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Singh, K, Rubenstein, K, Callier, V, Shaw-Saliba, K, Rupert, A, Dewar, R, Laverdure, S, Highbarger, H, Lallemand, P, Huang, M-L, Jerome, K R, Sampoleo, R, Mills, M G, Greninger, A L, Juneja, K, Porter, D, Benson, C A, Dempsey, W, El Sahly, H M, Focht, C, Jilg, N, Paules, C I, Rapaka, R R, Uyeki, T M, Lane, H C, Beigel, J, Dodd, L E, Adaptive COVID-19 Treatment Trial (ACTT-1) Study Group Members & Nielsen, H 2024, 'SARS-CoV-2 RNA and nucleocapsid antigen are blood biomarkers associated with severe disease outcomes that improve in response to remdesivir', The Journal of Infectious Diseases, vol. 230, no. 3, jiae198, pp. 624-634. https://doi.org/10.1093/infdis/jiae198
The Journal of Infectious Diseases, vol 230, iss 3
Singh, K, Rubenstein, K, Callier, V, Shaw-Saliba, K, Rupert, A, Dewar, R, Laverdure, S, Highbarger, H, Lallemand, P, Huang, M-L, Jerome, K R, Sampoleo, R, Mills, M G, Greninger, A L, Juneja, K, Porter, D, Benson, C A, Dempsey, W, El Sahly, H M, Focht, C, Jilg, N, Paules, C I, Rapaka, R R, Uyeki, T M, Lane, H C, Beigel, J, Dodd, L E & Adaptive COVID-19 Treatment Trial (ACTT-1) Study Group Members 2024, 'SARS-CoV-2 RNA and nucleocapsid antigen are blood biomarkers associated with severe disease outcomes that improve in response to remdesivir', The Journal of Infectious Diseases, vol. 230, no. 3, pp. 624-634. https://doi.org/10.1093/infdis/jiae198Predmety: Male, Adult, 0301 basic medicine, COVID-19/blood, remdesivir, antiviral efficacy, Antiviral Agents, Adenosine Monophosphate/analogs & derivatives, Coronavirus Nucleocapsid Proteins/immunology, SARS-CoV-2/immunology, 03 medical and health sciences, 0302 clinical medicine, Humans, Coronavirus Nucleocapsid Proteins, Viral, RNA, Viral/blood, Antigens, Antigens, Viral, Aged, Antiviral Agents/therapeutic use, Alanine, SARS-CoV-2, COVID-19, clinical trial, Alanine/analogs & derivatives, antiviral efficacy, clinical trial, COVID-19, remdesivir, SARS-CoV-2, Middle Aged, Viral Load, Adenosine Monophosphate, COVID-19 Drug Treatment, 3. Good health, Antigens, Viral/blood, Treatment Outcome, RNA, RNA, Viral, Female, Biomarkers/blood, Biomarkers
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38657001
https://vbn.aau.dk/da/publications/848d0595-5d78-4048-abfa-86e65c031503
https://doi.org/10.1093/infdis/jiae198
http://www.scopus.com/inward/record.url?scp=85204819223&partnerID=8YFLogxK
https://vbn.aau.dk/ws/files/705491966/Singh_et_al._2024_._SARS-CoV-2_RNA_and_nucleocapsid_antigen_are_blood_biomarkers_associated_with_severe_disease_outcomes_that_improve_in_response_to_remdesivir.pdf
https://escholarship.org/content/qt2hf3r271/qt2hf3r271.pdf
https://escholarship.org/uc/item/2hf3r271 -
3
Autori: a ďalší
Zdroj: J Viral Hepat
Journal of viral hepatitis
JOURNAL OF VIRAL HEPATITISPredmety: HBV‐HDV coinfection, Male, Liver Cirrhosis, Adult, Hepatitis D, Chronic, Coinfection/virology, HBV-HDV coinfection, viral hepatitis, Sciences de la santé humaine, Severity of Illness Index, Hepatitis B, Chronic, hepatitis delta virus, Risk Factors, Virology, Medicine and Health Sciences, Ethnicity, EPIDEMIOLOGY, Humans, Hepatitis Antibodies, Hepatitis D, Chronic/complications, RNA, Viral/blood, Human health sciences, Retrospective Studies, Aged, viremia, Hepatitis B Surface Antigens, Hepatology, Coinfection, Gastroentérologie & hépatologie, Middle Aged, Hepatitis D, Hepatitis Delta Virus/genetics, Infectious Diseases, Liver Cirrhosis/virology, DNA, Viral, Disease Progression, VIRUS, RNA, Viral, Original Article, Female, Human medicine, Hepatitis Delta Virus, Hepatitis D/epidemiology, hepatitis B virus, Gastroenterology & hepatology, Hepatitis Antibodies/blood, Follow-Up Studies
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39846497
https://repository.uantwerpen.be/docstore/d:irua:27560
https://hdl.handle.net/10067/2116580151162165141
http://hdl.handle.net/1854/LU-01JKQAC5EY5KGSK5SG6AB1R7MN
https://biblio.ugent.be/publication/01JKQAC5EY5KGSK5SG6AB1R7MN
http://doi.org/10.1111/jvh.14060
https://biblio.ugent.be/publication/01JKQAC5EY5KGSK5SG6AB1R7MN/file/01JKQACZX8F8AYE226MH4AA36Z -
4
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Aggarwal, N R, Nordwall, J, Braun, D L, Chung, L, Coslet, J, Der, T, Eriobu, N, Ginde, A A, Hayanga, A J, Highbarger, H, Holodniy, M, Horcajada, J P, Jain, M K, Kim, K, Laverdure, S, Lundgren, J, Natarajan, V, Nguyen, H H, Pett, S L, Phillips, A, Poulakou, G, Price, D A, Robinson, P, Rogers, A J, Sandkovsky, U, Shaw-Saliba, K, Sturek, J M, Trautner, B W, Waters, M, Reilly, C, ACTIV-3/TICO Study Group, Nielsen, H, Thisted, R K, Petersen, K T & Juhl, M R 2024, 'Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19', Clinical Infectious Diseases, vol. 78, no. 6, ciad780, pp. 1490-1503. https://doi.org/10.1093/cid/ciad780
Clinical Infectious Diseases, vol 78, iss 6Predmety: Microbiology (medical), Male, Adult, 0301 basic medicine, Medical Sciences, Epidemiology, 610 Medicine & health, Antibodies, Viral, 142-005 142-005, Antiviral Agents, Antibodies, 10234 Clinic for Infectious Diseases, 03 medical and health sciences, Antibodies, Viral/blood, acute COVID-19, Medical Specialties, Medicine and Health Sciences, host response, Humans, Clinical Epidemiology, Viral, RNA, Viral/blood, Antigens, Antigens, Viral, viral factors, Aged, Antiviral Agents/therapeutic use, COVID-19/mortality, 0303 health sciences, SARS-CoV-2, Interleukin-6, COVID-19, Middle Aged, COVID-19 Drug Treatment, 3. Good health, Antigens, Viral/blood, Hospitalization, Infectious Diseases, Acute COVID-19, RNA, RNA, Viral, Female, Public Health, Interleukin-6/blood
Popis súboru: application/pdf; ciad780.pdf - application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38376212
https://vbn.aau.dk/da/publications/e9c0cb99-dc7d-4c62-bd40-6881b1a6c2d4
https://doi.org/10.1093/cid/ciad780
http://www.scopus.com/inward/record.url?scp=85191029545&partnerID=8YFLogxK
https://pergamos.lib.uoa.gr/uoa/dl/object/3483684
https://discovery-pp.ucl.ac.uk/id/eprint/10188073/
https://escholarship.org/uc/item/232910xd
https://escholarship.org/content/qt232910xd/qt232910xd.pdf
https://www.zora.uzh.ch/id/eprint/258807/
https://doi.org/10.5167/uzh-258807 -
5
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: J Infect Dis
The Journal of infectious diseases, vol. 230, no. 4, pp. e954-e963Predmety: Male, Adult, 0301 basic medicine, Hepatitis B virus, Anti-HIV Agents, hepatitis B core-related antigen, HIV Infections, Cohort Studies, 03 medical and health sciences, Hepatitis B, Chronic, Major Article, Humans, Tenofovir, 0303 health sciences, Hepatitis B Surface Antigens, Tenofovir/therapeutic use, HIV Infections/drug therapy, HIV Infections/blood, HIV Infections/complications, HIV Infections/virology, Hepatitis B Surface Antigens/blood, Female, RNA, Viral/blood, Hepatitis B virus/genetics, Hepatitis B Core Antigens/blood, Coinfection/drug therapy, Coinfection/virology, Middle Aged, Hepatitis B/drug therapy, Hepatitis B/blood, Hepatitis B/virology, Anti-HIV Agents/therapeutic use, Switzerland/epidemiology, Viral Load, Hepatitis B, Chronic/drug therapy, Hepatitis B, Chronic/blood, Hepatitis B, Chronic/virology, Hepatitis B, Chronic/complications, DNA, Viral/blood, HBV RNA, HIV, hepatitis B core–related antigen, hepatitis B virus, kinetics, Coinfection, Hepatitis B, Hepatitis B Core Antigens, 3. Good health, DNA, Viral, RNA, Viral, Switzerland
Popis súboru: application/pdf
-
6
Autori: a ďalší
Zdroj: Annals of Internal Medicine
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
instname
ACTIV-3/TICO Bamlanivimab Study Group & Nielsen, H 2022, 'Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial', Annals of Internal Medicine, vol. 175, no. 2, pp. 234–243. https://doi.org/10.7326/M21-3507
ACTIV-3/TICO Bamlanivimab Study Group* & Johansen, I S 2022, ' Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial ', Annals of Internal Medicine, vol. 175, no. 2, pp. 234-243 . https://doi.org/10.7326/M21-3507
ACTIV-3/TICO Bamlanivimab Study Group & Østergaard, L J 2022, 'Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial', Annals of Internal Medicine, vol. 175, no. 2, pp. 234-243. https://doi.org/10.7326/M21-3507Predmety: Male, 0301 basic medicine, COVID-19/blood, Antibodies, Monoclonal, Humanized, Antiviral Agents, 12. Responsible consumption, 03 medical and health sciences, Double-Blind Method, Humans, RNA, Viral/blood, Treatment Failure, Adenosine Monophosphate/adverse effects, Antigens, Viral, Aged, 0303 health sciences, Alanine, SARS-CoV-2, COVID-19, Middle Aged, 16. Peace & justice, Antiviral Agents/adverse effects, Antibodies, Neutralizing, Antibodies, Neutralizing/adverse effects, Adenosine Monophosphate, COVID-19 Drug Treatment, 3. Good health, Antigens, Viral/blood, Antibodies, Monoclonal, Humanized/adverse effects, Alanine/adverse effects, RNA, Viral, Drug Therapy, Combination, Female, Medical Futility, Biomarkers/blood, Biomarkers
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/34928698
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=5085
https://vbn.aau.dk/da/publications/c530ec33-9c51-477d-98fa-36df01391484
http://www.scopus.com/inward/record.url?scp=85122944410&partnerID=8YFLogxK
https://doi.org/10.7326/M21-3507
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334931/pdf/nihms-1818621.pdf
https://portal.findresearcher.sdu.dk/da/publications/45f270f1-41e6-4078-b1c4-3181574e6306
https://doi.org/10.7326/M21-3507
https://portal.findresearcher.sdu.dk/da/publications/45f270f1-41e6-4078-b1c4-3181574e6306 -
7
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: The Lancet. 393:143-155
Predmety: Male, Lamivudine / therapeutic use, HIV Dolutegravir, Heterocyclic Compounds, 3-Ring / therapeutic use, Tenofovir / therapeutic use, HIV Infections, Viral Load / drug effects, Piperazines, 0302 clinical medicine, Emtricitabine / therapeutic use, Emtricitabine, Tenofovir/adverse effects, Lamivudine/adverse effects, Adult, Anti-HIV Agents, Anti-Retroviral Agents, Double-Blind Method, Drug Therapy, Combination, Female, HIV-1, Heterocyclic Compounds, 3-Ring, Humans, Lamivudine, Middle Aged, RNA, Viral, Tenofovir, Viral Load, Medicine (all), HIV Infections / virology, Heterocyclic Compounds, 3-Ring/adverse effects, 16. Peace & justice, Emtricitabine/adverse effects, Anti-Retroviral Agents / adverse effects, Anti-Retroviral Agents / therapeutic use, HIV-1 / isolation & purification, 3. Good health, [SDV] Life Sciences [q-bio], Anti-HIV Agents / adverse effects, Anti-HIV Agents / therapeutic use, Heterocyclic Compounds, 3-Ring / adverse effects, Tenofovir / adverse effects, Pyridones, HIV Infections/drug therapy, Lamivudine / adverse effects, Anti-Retroviral Agents/adverse effects, 03 medical and health sciences, Emtricitabine / adverse effects, SDG 3 - Good Health and Well-being, Oxazines, HIV-1/isolation & purification, RNA, Viral/blood, Viral Load/drug effects, HIV Infections / drug therapy, Anti-HIV Agents/adverse effects, RNA, Viral / blood
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/30420123
https://air.unimi.it/handle/2434/629086
https://www.sciencedirect.com/science/article/abs/pii/S0140673618324620#!
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)32462-0/fulltext
https://research.monash.edu/en/publications/dolutegravir-plus-lamivudine-versus-dolutegravir-plus-tenofovir-d
https://iris.unimore.it/handle/11380/1221490
https://www.sciencedirect.com/science/article/abs/pii/S0140673618324620
https://biblio.vub.ac.be/vubir/(1ae261bf-adab-4c02-9192-55337e187a2e).html -
8
Autori: a ďalší
Zdroj: Eur J Clin Microbiol Infect Dis
European Journal of Clinical Microbiology & Infectious DiseasesPredmety: Microbiology (medical), Male, 0301 basic medicine, Pneumonia, Viral, Oropharynx, COVID-19, Aged, 80 and over [MeSH], Aged [MeSH], COVID-19 Testing [MeSH], Coronavirus Infections/blood [MeSH], Coronavirus Infections/mortality [MeSH], RNA, Viral/blood [MeSH], COVID-19 diagnostic testing, Germany/epidemiology [MeSH], Pneumonia, Viral/blood [MeSH], Original Article, Sensitivity and Specificity [MeSH], Male [MeSH], COVID-19 [MeSH], Nasopharynx/virology [MeSH], False Negative Reactions [MeSH], SARS-CoV-2 [MeSH], Clinical Laboratory Techniques/methods [MeSH], SARS-CoV-2, Specificity and sensitivity, Betacoronavirus/pathogenicity [MeSH], Female [MeSH], Oropharynx/virology [MeSH], Coronavirus Infections/diagnosis [MeSH], Betacoronavirus/genetics [MeSH], Humans [MeSH], False-negative reactions, Severity of Illness Index [MeSH], Survival Analysis [MeSH], RNA, Viral/genetics [MeSH], Retrospective Studies [MeSH], Coronavirus Infections/epidemiology [MeSH], Pandemics [MeSH], Pneumonia, Viral/mortality [MeSH], Loop-mediated isothermal amplification, Reagent Kits, Diagnostic/standards [MeSH], Pneumonia, Viral/diagnosis [MeSH], Reverse Transcriptase Polymerase Chain Reaction/standards [MeSH], Nucleic Acid Amplification Techniques/methods [MeSH], Molecular Diagnostic Techniques/methods [MeSH], Pneumonia, Viral/epidemiology [MeSH], Infectious disease outbreaks, Betacoronavirus, 03 medical and health sciences, COVID-19 Testing, Germany, Nasopharynx, Humans, False Negative Reactions, Pandemics, Aged, Aged, 80 and over, 0303 health sciences, Clinical Laboratory Techniques, General Medicine, ddc, 3. Good health, Infectious Diseases, Molecular Diagnostic Techniques, RNA, Viral, Female, Reagent Kits, Diagnostic, Coronavirus Infections, Nucleic Acid Amplification Techniques
Popis súboru: application/pdf
Prístupová URL adresa: https://mediatum.ub.tum.de/doc/1575875/document.pdf
https://link.springer.com/content/pdf/10.1007/s10096-020-03983-9.pdf
https://pubmed.ncbi.nlm.nih.gov/32681309
https://www.researchsquare.com/article/rs-33871/v1
https://europepmc.org/article/MED/32681309
https://www.researchsquare.com/article/rs-33871/v1.pdf?c=1631857297000
https://www.scilit.net/article/d6f2766d29e309a08e1783fa63c789c6
https://doi.org/10.1007/s10096-020-03983-9
https://link.springer.com/article/10.1007/s10096-020-03983-9
https://repository.publisso.de/resource/frl:6468144
https://mediatum.ub.tum.de/1575875 -
9
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: New England Journal of Medicine, Vol. 381, No 9 (2019) pp. 816-826
Predmety: Adult, Cyclopropanes, Male, INFECTIOUS_DISEASES, Pyridones, HIV Infections/drug therapy, HIV Infections, THERAPY, Piperazines, Tenofovir/administration & dosage, 03 medical and health sciences, Benzoxazines/administration & dosage/adverse effects, 0302 clinical medicine, Pregnancy, Oxazines, Humans, RNA, Viral/blood, HIV Integrase Inhibitors, Obesity, Tenofovir, ddc:616, Weight Gain/drug effects, ADULTS, Heterocyclic Compounds, 3-Ring/administration & dosage/adverse effects, 16. Peace & justice, Viral Load/drug effects, HIV-1/genetics/isolation & purification, Benzoxazines, 3. Good health, AIDS, Lamivudine/administration & dosage, Lamivudine, [SDV.SP.PHARMA] Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, Alkynes, CAMEROON, HIV Integrase Inhibitors/adverse effects/therapeutic use, [SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases, HIV-1, Obesity/chemically induced, RNA, Viral, Drug Therapy, Combination, Female, Heterocyclic Compounds, 3-Ring
Popis súboru: application/pdf; pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/31339676
https://pubmed.ncbi.nlm.nih.gov/31339676/
https://hal.archives-ouvertes.fr/hal-02479607/document
https://hal.archives-ouvertes.fr/hal-02479607
https://www.ncbi.nlm.nih.gov/pubmed/31339676
https://hal.science/hal-02479607v1
https://hal.science/hal-02479607v1/document
https://doi.org/10.1056/nejmoa1904340
https://archive-ouverte.unige.ch/unige:145652
https://archive-ouverte.unige.ch/unige:145652
https://doi.org/10.1056/nejmoa1904340
http://hdl.handle.net/20.500.12204/e89TSJQBiCFEh8T3c_Om -
10
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: New England Journal of Medicine. 381:803-815
Predmety: Male, Phosphorous Acids, Clinical Trial, Phase III, HIV Infections, GUIDELINES, RECOMMENDATIONS, Piperazines, Anti-Retroviral Agents/administration & dosage, ANTIRETROVIRAL THERAPY, PROGRAMS, Heterocyclic Compounds, Bone Density, Pregnancy, INFECTION, Prodrugs, Viral, Pregnancy Complications, Infectious, 11 Medical and Health Sciences, Research Support, Non-U.S. Gov't, Infectious, General Medicine, Viral Load, Middle Aged, Intention to Treat Analysis, 3. Good health, Anti-Retroviral Agents, OBESITY, Combination, Randomized Controlled Trial, Medicine, RNA, Viral, Drug Therapy, Combination, Female, Life Sciences & Biomedicine, Heterocyclic Compounds, 3-Ring, Adult, HIV-1/genetics, Adolescent, HIV Infections/drug therapy, General & Internal, 3-Ring, EFAVIRENZ, Young Adult, Medicine, General & Internal, Prodrugs/administration & dosage, Drug Therapy, General & Internal Medicine, Oxazines, Journal Article, Humans, Adenine/administration & dosage, Comparative Study, RNA, Viral/blood, HIV Integrase Inhibitors, Uracil, Science & Technology, Uracil/administration & dosage, Adenine, Heterocyclic Compounds, 3-Ring/administration & dosage, Pregnancy Complications, Infectious/drug therapy, Bone Density/drug effects, ADULTS, Phosphorous Acids/administration & dosage, EFFICACY, RISKS, CD4 Lymphocyte Count, Pregnancy Complications, HIV Integrase Inhibitors/administration & dosage, HIV-1, RNA
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/31339677
https://europepmc.org/abstract/MED/31339677
https://pesquisa.bvsalud.org/portal/resource/pt/mdl-31339677
https://www.nejm.org/doi/full/10.1056/NEJMoa1902824
https://dspace.library.uu.nl/handle/1874/389279
https://www.narcis.nl/publication/RecordID/oai%3Adspace.library.uu.nl%3A1874%2F389279
https://pubmed.ncbi.nlm.nih.gov/31339677/
https://dspace.library.uu.nl/handle/1874/389279
http://hdl.handle.net/10044/1/81878 -
11
Autori: a ďalší
Zdroj: Emerging Microbes & Infections
Emerg Microbes Infect
Emerging Microbes and Infections, Vol 8, Iss 1, Pp 613-623 (2019)
Emerging Microbes & Infections, Vol. 8, No 1 (2019) pp. 613-623
Emerging microbes & infections, vol. 8, no. 1, pp. 613-623
Cordey, Samuel; Laubscher, Florian; Hartley, Mary-Anne; Junier, Thomas; Pérez-Rodriguez, Francisco J; Keitel, Kristina; Vieille, Gael; Samaka, Josephine; Mlaganile, Tarsis; Kagoro, Frank; Boillat-Blanco, Noémie; Mbarack, Zainab; Docquier, Mylène; Brito, Francisco; Eibach, Daniel; May, Jürgen; Sothmann, Peter; Aldrich, Cassandra; Lusingu, John; Tapparel, Caroline; ... (2019). Detection of dicistroviruses RNA in blood of febrile Tanzanian children. Emerging microbes & infections, 8(1), pp. 613-623. Taylor & Francis 10.1080/22221751.2019.1603791 <http://dx.doi.org/10.1080/22221751.2019.1603791>Predmety: 576.5, Male, 0301 basic medicine, de novo analysis, Fever, Epidemiology, Immunology, 610 Medicine & health, Virus Diseases/blood/genetics/virology, Infectious and parasitic diseases, RC109-216, Viral/blood, sera, Tanzanian children, Polymerase Chain Reaction, Tanzania, Microbiology, Article, Cohort Studies, 03 medical and health sciences, ddc:590, Virology, Drug Discovery, Humans, ddc:576.5, Preschool, Child, Phylogeny, ddc:616, 0303 health sciences, viremia, Infant, Fever/blood/virology, General Medicine, Dicistrovirus, QR1-502, 3. Good health, Infectious Diseases, Viruses/classification/isolation & purification, Virus Diseases, Child, Preschool, Viruses, RNA, RNA, Viral, Female, Parasitology, Fever/blood, Fever/virology, RNA, Viral/blood, Virus Diseases/blood, Virus Diseases/genetics, Virus Diseases/virology, Viruses/classification, Viruses/isolation & purification
Popis súboru: application/pdf
Prístupová URL adresa: https://www.tandfonline.com/doi/pdf/10.1080/22221751.2019.1603791?needAccess=true
https://pubmed.ncbi.nlm.nih.gov/30999808
https://doaj.org/article/a5be99b5fe8f4a26a02b3af3ed43f439
https://www.ncbi.nlm.nih.gov/pubmed/30999808
https://archive-ouverte.unige.ch/unige:122919/ATTACHMENT01
https://archive-ouverte.unige.ch/unige:122919
https://tandfonline.com/doi/pdf/10.1080/22221751.2019.1603791
https://europepmc.org/abstract/MED/30999808
https://serval.unil.ch/resource/serval:BIB_EC0E536871A0.P001/REF.pdf
https://archive-ouverte.unige.ch/unige:122919
https://serval.unil.ch/resource/serval:BIB_EC0E536871A0.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_EC0E536871A0
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_EC0E536871A00
https://edoc.unibas.ch/70293/
https://boris.unibe.ch/160557/ -
12
Autori: a ďalší
Zdroj: Nature medicine
Nature MedicinePredmety: Male, 0301 basic medicine, Reinfection/blood, Time Factors, Coronavirus Infections/blood, Coronavirus/genetics, COVID-19/prevention & control, HIV Infections, Adaptive Immunity, Immunologie & maladie infectieuse, Cohort Studies, Reinfection/immunology, Coinfection/blood, Immunology & infectious disease, Human health sciences, COVID-19/epidemiology, Netherlands, Aged, 80 and over, 0303 health sciences, Coinfection, General Medicine, Middle Aged, 3. Good health, COVID-19/immunology, Chemistry, HIV Infections/epidemiology, RNA, Viral, Seasons, Coronavirus Infections, Adult, Coronavirus Infections/virology, Adolescent, COVID-19/blood, HIV Infections/complications, Netherlands/epidemiology, Reinfection/epidemiology, Sciences de la santé humaine, SARS-CoV-2/immunology, General Biochemistry, Genetics and Molecular Biology, Coronavirus Infections/immunology, Young Adult, 03 medical and health sciences, SARS-CoV-2/genetics, Coinfection/epidemiology, Humans, Serologic Tests, RNA, Viral/blood, Adaptive Immunity/physiology, Biology, Pandemics, Aged, Biochemistry, Genetics and Molecular Biology (all), Serologic Tests/methods, SARS-CoV-2, COVID-19, Coronavirus/immunology, Coronavirus, RNA, Viral/analysis, Reinfection, Coronavirus Infections/epidemiology, Human medicine, Reinfection/virology, Follow-Up Studies
-
13
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Nat Commun
Repisalud
Instituto de Salud Carlos III (ISCIII)
Nature Communications, Vol 12, Iss 1, Pp 1-17 (2021)
Gutmann, C, Takov, K, Burnap, S A, Singh, B, Ali, H, Theofilatos, K, Reed, E, Hasman, M, Nabeebaccus, A, Fish, M, McPhail, M J, O'Gallagher, K, Schmidt, L E, Cassel, C, Rienks, M, Yin, X, Auzinger, G, Napoli, S, Mujib, S F, Trovato, F, Sanderson, B, Merrick, B, Niazi, U, Saqi, M, Dimitrakopoulou, K, Fernández-Leiro, R, Braun, S, Kronstein-Wiedemann, R, Doores, K J, Edgeworth, J D, Shah, A M, Bornstein, S R, Tonn, T, Hayday, A C, Giacca, M, Shankar-Hari, M & Mayr, M 2021, 'SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care', Nature Communications, vol. 12, no. 1, 3406. https://doi.org/10.1038/s41467-021-23494-1
Gutmann, C, Takov, K, Burnap, S A, Singh, B, Ali, H, Theofilatos, K, Reed, E, Hasman, M, Nabeebaccus, A, Fish, M, McPhail, M J, O'Gallagher, K, Schmidt, L E, Cassel, C, Rienks, M, Yin, X, Auzinger, G, Napoli, S, Mujib, S F, Trovato, F, Sanderson, B, Merrick, B, Niazi, U, Saqi, M, Dimitrakopoulou, K, Fernández-Leiro, R, Braun, S, Kronstein-Wiedemann, R, Doores, K J, Edgeworth, J D, Shah, A M, Bornstein, S R, Tonn, T, Hayday, A C, Giacca, M, Shankar-Hari, M & Mayr, M 2021, ' SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care ', Nature Communications, vol. 12, no. 1, 3406 . https://doi.org/10.1038/s41467-021-23494-1
Gutmann, C, Takov, K, Burnap, S A, Singh, B, Ali, H, Theofilatos, K, Reed, E, Hasman, M, Nabeebaccus, A, Fish, M, McPhail, M J, O'Gallagher, K, Schmidt, L E, Cassel, C, Rienks, M, Yin, X, Auzinger, G, Napoli, S, Mujib, S F, Trovato, F, Sanderson, B, Merrick, B, Niazi, U, Saqi, M, Dimitrakopoulou, K, Fernández-Leiro, R, Braun, S, Kronstein-Wiedemann, R, Doores, K J, Edgeworth, J D, Shah, A M, Bornstein, S R, Tonn, T, Hayday, A C, Giacca, M, Shankar-Hari, M & Mayr, M 2021, ' SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care ', Nature Communications, vol. 12, no. 1, pp. 3406 . https://doi.org/10.1038/s41467-021-23494-1Predmety: Male, Proteomics, 0301 basic medicine, HEPARAN-SULFATE PROTEOGLYCANS, Kaplan-Meier Estimate, Viral/blood, DISEASE, ACTIVATION, Tumor/metabolism, 2. Zero hunger, Serum Amyloid P-Component/metabolism, 0303 health sciences, COVID-19/metabolism, Antigens, Neoplasm/metabolism, GLYCOPROTEIN, Middle Aged, Viral Load, Antibodies, Neutralizing/immunology, Spike Glycoprotein, 3. Good health, Serum Amyloid P-Component, Neoplasm/metabolism, C-Reactive Protein, Spike Glycoprotein, Coronavirus, RNA, Viral, Female, Proteomics/methods, Adult, Critical Care, Science, INHIBITION, Antibodies, Article, 03 medical and health sciences, SARS-CoV-2/genetics, Antigens, Neoplasm, MANNOSE-BINDING LECTIN, Biomarkers, Tumor, LONG PENTRAXIN PTX3, Animals, Humans, RNA, Viral/blood, Antigens, SEPSIS, SARS-CoV-2, C-Reactive Protein/metabolism, Viral Load/immunology, INTERNATIONAL CONSENSUS DEFINITIONS, Critical Care/statistics & numerical data, SEPTIC SHOCK, COVID-19, Coronavirus/immunology, Antibodies, Neutralizing, Neutralizing/immunology, HEK293 Cells, Biomarkers, Tumor/metabolism, RNA, Spike Glycoprotein, Coronavirus/immunology, Biomarkers
Popis súboru: application/pdf
Prístupová URL adresa: https://www.nature.com/articles/s41467-021-23494-1.pdf
https://pubmed.ncbi.nlm.nih.gov/34099652
https://hdl.handle.net/20.500.12105/23565
https://doaj.org/article/4473e05193134fe3b894751bffb9a062
https://kclpure.kcl.ac.uk/portal/en/publications/sarscov2-rnaemia-and-proteomic-trajectories-inform-prognostication-in-covid19-patients-admitted-to-intensive-care(8d565478-1e85-4136-b417-ba1f33437946).html
https://www.nature.com/articles/s41467-021-23494-1
https://europepmc.org/article/MED/34099652
https://pubmed.ncbi.nlm.nih.gov/34099652/
https://www.nature.com/articles/s41467-021-23494-1.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184784/
https://kclpure.kcl.ac.uk/ws/files/153943399/SARS_CoV_2_RNAemia_and_proteomic_trajectories_inform_prognostication_in_COVID_19_patients_admitted_to_intensive_care_Nature_Communications_07.06.2021.pdf
https://www.pure.ed.ac.uk/ws/files/263687109/s41467_021_23494_1.pdf
https://hdl.handle.net/20.500.11820/2a4e4ea8-5731-47f9-9de4-c3457f254c5c -
14
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Clinical Infectious Diseases. 66:1099-1108
Predmety: HIV Infections / immunology, Adult, Male, Viral Vaccines / therapeutic use, Immunization, Secondary, 610 Medicine & health, HIV Infections, Yellow Fever / prevention & control, Antibodies, Viral, 2726 Microbiology (medical), Cohort Studies, Antibodies, Viral / blood, 03 medical and health sciences, Immunogenicity, Vaccine, 0302 clinical medicine, Antibodies, Neutralizing / blood, Yellow Fever, Humans, Prospective Studies, Immunization Schedule, Viral Vaccines, 2725 Infectious Diseases, Middle Aged, 16. Peace & justice, Antibodies, Neutralizing, Anti-Retroviral Agents / therapeutic use, HIV Infections / drug therapy, 3. Good health, Anti-Retroviral Agents, 10036 Medical Clinic, RNA, Viral, Regression Analysis, Female, RNA, Viral / blood
Popis súboru: application/pdf
Prístupová URL adresa: https://academic.oup.com/cid/article-pdf/66/7/1099/24398230/cix960.pdf
https://pubmed.ncbi.nlm.nih.gov/29140432
https://www.ncbi.nlm.nih.gov/pubmed/29140432
https://serval.unil.ch/notice/serval:BIB_8CD1FBD6BDA7
https://academic.oup.com/cid/article/66/7/1099/4616867
https://www.zora.uzh.ch/152170
https://archive-ouverte.unige.ch/unige:173231
https://doi.org/10.1093/cid/cix960 -
15
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: RUC. Repositorio da Universidade da Coruña
instnamePredmety: Adult, Male, 0301 basic medicine, HIV-1/genetics, Virus replication, HIV Infections, Real-Time Polymerase Chain Reaction, Virus Replication, DNA, Mitochondrial, DNA, Mitochondrial/blood, Cohort Studies, Plasma, 03 medical and health sciences, Blood HIV RNA, Virology, Biological makers, Humans, Viral load, RNA, Viral/blood, Viremia, CD4 count determination procedure, 0303 health sciences, HIV, DNA, Middle Aged, Viral Load, HIV infection, Mitochondrial, CD4 Lymphocyte Count, 3. Good health, Spain, HIV Infections/epidemiology, Spain/epidemiology, HIV-1, Cohort studies, RNA, Viral, Female, Biomarkers/blood, Biomarkers
Prístupová URL adresa: https://academic.oup.com/jac/article-pdf/72/11/3159/21359397/dkx272.pdf
https://pubmed.ncbi.nlm.nih.gov/28961892
http://hdl.handle.net/2183/20799
https://europepmc.org/abstract/MED/28961892
https://academic.oup.com/jac/article/72/11/3159/4101634
http://academic.oup.com/jac/article/72/11/3159/4101634/Plasma-mitochondrial-DNA-levels-are-inversely
https://www.ncbi.nlm.nih.gov/pubmed/28961892
https://hdl.handle.net/20.500.14017/3c73b92c-170c-4c64-9904-0a3e5128e86b
https://doi.org/10.1093/jac/dkx272
https://biblio.vub.ac.be/vubir/(3c73b92c-170c-4c64-9904-0a3e5128e86b).html -
16
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: HIV Medicine, Vol. 19, No 1 (2018) pp. 42-48
Predmety: Combination antiretroviral therapy, Adult, Male, Adolescent, combination antiretroviral therapy, HIV, immunovirological response, migrants, sex, HIV Infections/drug therapy, HIV Infections, Anti-Retroviral Agents/therapeutic use, Cohort Studies, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Population Groups, Antiretroviral Therapy, Highly Active, Humans, Pharmacology (medical), Immunovirological response, RNA, Viral/blood, 10. No inequality, Aged, ddc:616, Transients and Migrants, Health Policy, Migrant, Middle Aged, Viral Load, 16. Peace & justice, Migrants, Sex, Infectious Diseases, CD4 Lymphocyte Count, 3. Good health, Europe, Treatment Outcome, Anti-Retroviral Agents, RNA, Viral, Female
Popis súboru: application/pdf
Prístupová URL adresa: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/hiv.12536
https://pubmed.ncbi.nlm.nih.gov/28741837
http://dspace.library.uu.nl/handle/1874/366154
https://iris.unimore.it/handle/11380/1155074
https://ricerca.uniba.it/handle/11586/203430
https://moh-it.pure.elsevier.com/en/publications/immunological-and-virological-response-to-antiretroviral-treatmen
https://boa.unimib.it/handle/10281/304402
https://core.ac.uk/display/132564143
http://www.wiley.com/bw/journal.asp?ref=1464-2662
https://hdl.handle.net/20.500.11768/68526
https://doi.org/10.1111/hiv.12536
https://pure.amsterdamumc.nl/en/publications/4fe266fa-671c-41b3-b806-a82b5d49b1dd
https://doi.org/10.1111/hiv.12536
https://archive-ouverte.unige.ch/unige:115834
https://archive-ouverte.unige.ch/unige:115834
https://doi.org/10.1111/hiv.12536
http://www.wiley.com/bw/journal.asp?ref=1464-2662
https://doi.org/10.1111/hiv.12536
https://hdl.handle.net/11380/1155074 -
17
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: European Journal of Gastroenterology & Hepatology. 29:781-785
Predmety: Adult, Male, 0301 basic medicine, Time Factors, Genotype, Sustained Virologic Response, Hepacivirus, Antiviral Agents, Drug Administration Schedule, 12. Responsible consumption, 03 medical and health sciences, Predictive Value of Tests, Humans, RNA, Viral/blood, Prospective Studies, Aged, 2. Zero hunger, 0303 health sciences, Hepacivirus/drug effects, Hepatitis C, Chronic, Middle Aged, Viral Load, Viral Load/drug effects, 3. Good health, Spain, RNA, Viral, Female, Drug Monitoring, Hepatitis C, Chronic/blood, Drug Monitoring/methods, Antiviral Agents/administration & dosage, Biomarkers/blood, Biomarkers
-
18
Autori: a ďalší
Zdroj: Nature Medicine, 26 (11), 1691 - 1693 (2020)
Predmety: RNA, Viral, Adaptive Immunity/physiology, Adolescent, Adult, Aged, Aged, 80 and over, Cohort Studies, Coinfection/blood, Coinfection/epidemiology, Coronavirus/genetics, Coronavirus/immunology, Coronavirus Infections/blood, Coronavirus Infections/epidemiology, Coronavirus Infections/immunology, Coronavirus Infections/virology, Follow-Up Studies, HIV Infections/complications, HIV Infections/epidemiology, Humans, Male, Middle Aged, Netherlands/epidemiology, Pandemics, RNA, Viral/analysis, RNA, Viral/blood, Reinfection/blood, Reinfection/epidemiology, Reinfection/immunology, Reinfection/virology, SARS-CoV-2/genetics, SARS-CoV-2/immunology, Serologic Tests/methods, Time Factors, Young Adult, COVID-19/blood, COVID-19/epidemiology, COVID-19/immunology, COVID-19/prevention & control, Seasons, Adaptive Immunity, Coinfection, Coronavirus, Coronavirus Infections, COVID-19, HIV Infections, Netherlands, Reinfection, SARS-CoV-2, Serologic Tests, Biochemistry, Genetics and Molecular Biology (all), General Biochemistry, Genetics and Molecular Biology, General Medicine, Human health sciences, Immunology & infectious disease, Sciences de la santé humaine, Immunologie & maladie infectieuse
Relation: https://www.nature.com/articles/s41591-020-1083-1.pdf; urn:issn:1078-8956; urn:issn:1546-170X
Prístupová URL adresa: https://orbi.uliege.be/handle/2268/299116
-
19
Autori: a ďalší
Zdroj: Laut, K G, Shepherd, L C, Pedersen, C, Rockstroh, J K, Sambatakou, H, Paduta, D, Matulionyte, R, Smiatacz, T, Mulcahy, F, Lundgren, J D, Mocroft, A, Kirk, O, Gatell, J, Gazzard, B, Horban, A, Karpov, I, Ledergerber, B, Losso, M, Monforte, A D A, Rakhmanova, A, Ristola, M, Phillips, A, Reiss, P, Lundgren, J, Rockstroh, J, De Wit, S, Rockstroh, J, De Wit, S, Kirk, O, Mocroft, A, Grarup, J, Reiss, P, Cozzi-Lepri, A, Thiebaut, R, Rockstroh, J, Burger, D, Paredes, R & Peters, L 2016, ' Associations between HIV-RNA-based indicators and virological and clinical outcomes ', AIDS, vol. 30, no. 12, pp. 1961-1972 . https://doi.org/10.1097/QAD.0000000000001144
Predmety: Adult, Male, HIV Infections, Viral/blood, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Journal Article, Health Status Indicators, Humans, RNA, Viral/blood, benchmarking, outcome assessment (healthcare), HIV, quality indicators, Middle Aged, Viral Load, Survival Analysis, viral load, 3. Good health, AIDS, HIV Infections/diagnosis, Treatment Outcome, RNA, RNA, Viral, Female, Drug Monitoring, Drug Monitoring/methods
Prístupová URL adresa: https://discovery.ucl.ac.uk/1494652/1/Mocroft_00002030-900000000-97775.pdf
https://pubmed.ncbi.nlm.nih.gov/27149091
https://pubmed.ncbi.nlm.nih.gov/27149091/
https://moh-it.pure.elsevier.com/en/publications/associations-between-hiv-rna -based-indicators-and-virological-and
https://discovery.ucl.ac.uk/id/eprint/1494652
http://www.scopus.com/inward/record.url?scp=84965017129&partnerID=8YFLogxK -
20
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: RUC. Repositorio da Universidade da Coruña
instnamePredmety: 0301 basic medicine, Adult, Male, Efficacy, Anti-HIV Agents, HIV Infections/drug therapy, Long Term Adverse Effects, HIV Infections, HIV Protease Inhibitors/administration & dosage, Drug Administration Schedule, Lopinavir, Anti-HIV Agents/administration & dosage, Ritonavir/administration & dosage, 03 medical and health sciences, 0302 clinical medicine, Humans, Lopinavir/adverse effects, RNA, Viral/blood, Darunavir, Retrospective Studies, 0303 health sciences, Sulfonamides, Ritonavir, Sulfonamides/adverse effects, HIV Protease Inhibitors, Viral Load, HIV infection, Viral Load/drug effects, 3. Good health, CD4 Lymphocyte Count, HIV-1/drug effects, Spain, Darunavir/administration & dosage, HIV-1, young adult, RNA, Viral, Drug Therapy, Combination, Female, Safety
Popis súboru: application/pdf
Prístupová URL adresa: https://ruc.udc.es/dspace/bitstream/2183/18373/2/Pernas_Long.pdf
https://pubmed.ncbi.nlm.nih.gov/27218208
http://hdl.handle.net/2183/18373
http://onlinelibrary.wiley.com/doi/10.1002/jmv.24585/abstract
http://europepmc.org/abstract/MED/27218208
https://ruc.udc.es/dspace/handle/2183/18373
https://ruc.udc.es/dspace/bitstream/2183/18373/2/Pernas_Long.pdf
https://hdl.handle.net/2183/18373
https://biblio.vub.ac.be/vubir/longterm-clinical-experience-with-darunavir-20072015-in-a-large-cohort-of-hivinfected-patients-in-spain(b5b097fd-31bf-48e3-a7e6-637a98d2735f).html
https://hdl.handle.net/20.500.14017/b5b097fd-31bf-48e3-a7e6-637a98d2735f
https://doi.org/10.1002/jmv.24585
Full Text Finder
Nájsť tento článok vo Web of Science